Docket Number:12A-941017, 12A-941017B
Inventor:Yijuang Chern, Yun-Lian Lin, Nai-Kuei Huang
IP Status:Issued US7,351,434,B2、US8,129,357、ZL200710091094.8、ZL200810179848.X、TW369213、TW372627
Abstract:
Huntington's disease (HD) is an autosomal dominant disease caused by a CAG trinucleotide expansion of exon 1 of the Huntingtin (Htt) gene. We recently found that a fraction of a Chinese herb and two compounds purified from this fraction can ameliorate major symptoms of HD in a transgenic mouse model of HD. The improved symptoms include:
- the progressive deterioration of motor performance,
- mutant protein aggregation in the brain and the liver,
- body waste, and
- lifespan.
These purified compounds might be used in the future to develop novel treatments for HD.
Fields of Application:
Treatment for Huntington's disease.
Advantages when compared to the existing technologies:
Effective, no detectable side effect, and can be applied to HD patients easily.
Contact Person:Mei-Fang Lee / 886-2-2787-2503 / mflee@gate.sinica.edu.tw
